1. Home
  2. CSTE vs CTSO Comparison

CSTE vs CTSO Comparison

Compare CSTE & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CSTE

Caesarstone Ltd.

N/A

Current Price

$0.74

Market Cap

27.7M

Sector

Industrials

ML Signal

N/A

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

N/A

Current Price

$0.77

Market Cap

45.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CSTE
CTSO
Founded
1987
1997
Country
Israel
United States
Employees
N/A
N/A
Industry
Building Materials
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.7M
45.7M
IPO Year
2012
2008

Fundamental Metrics

Financial Performance
Metric
CSTE
CTSO
Price
$0.74
$0.77
Analyst Decision
Buy
Buy
Analyst Count
1
2
Target Price
$5.00
$5.38
AVG Volume (30 Days)
319.6K
67.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$22,503,908.00
Revenue This Year
N/A
$7.29
Revenue Next Year
$1.59
$8.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
48.53
52 Week Low
$0.71
$0.60
52 Week High
$3.26
$1.39

Technical Indicators

Market Signals
Indicator
CSTE
CTSO
Relative Strength Index (RSI) 19.98 54.78
Support Level N/A $0.62
Resistance Level $2.00 $0.84
Average True Range (ATR) 0.16 0.04
MACD -0.08 0.01
Stochastic Oscillator 3.60 59.46

Price Performance

Historical Comparison
CSTE
CTSO

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: